Vibol Tan

Array ( [id] => 7105356 [patent_doc_number] => 20010004529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-06-21 [patent_title] => 'Compositions to enhance the efficacy and safety of bio-pharmaceutical drugs' [patent_app_type] => new-utility [patent_app_number] => 09/783115 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10254 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20010004529.pdf [firstpage_image] =>[orig_patent_app_number] => 09783115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1395967 [patent_doc_number] => 06537745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-25 [patent_title] => 'Buffers for stabilizing antigens' [patent_app_type] => B2 [patent_app_number] => 09/775962 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6214 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537745.pdf [firstpage_image] =>[orig_patent_app_number] => 09775962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1499213 [patent_doc_number] => 06485724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-11-26 [patent_title] => 'Immortalized human keratinocyte cell line' [patent_app_type] => B2 [patent_app_number] => 09/769124 [patent_app_country] => US [patent_app_date] => 2001-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 15015 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/485/06485724.pdf [firstpage_image] =>[orig_patent_app_number] => 09769124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6896775 [patent_doc_number] => 20010027565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-04 [patent_title] => 'Binding protein' [patent_app_type] => new [patent_app_number] => 09/755251 [patent_app_country] => US [patent_app_date] => 2001-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8559 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20010027565.pdf [firstpage_image] =>[orig_patent_app_number] => 09755251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032089 [patent_doc_number] => 20020018784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Vaccine against mumps containing a jeryl-lynn virus strain' [patent_app_type] => new [patent_app_number] => 09/748343 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5083 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20020018784.pdf [firstpage_image] =>[orig_patent_app_number] => 09748343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128413 [patent_doc_number] => 20020076415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Hepatitis C virus gene products' [patent_app_type] => new [patent_app_number] => 09/736959 [patent_app_country] => US [patent_app_date] => 2000-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14271 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076415.pdf [firstpage_image] =>[orig_patent_app_number] => 09736959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1234550 [patent_doc_number] => 06689370 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence' [patent_app_type] => B1 [patent_app_number] => 09/722328 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5606 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689370.pdf [firstpage_image] =>[orig_patent_app_number] => 09722328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1178281 [patent_doc_number] => 06740323 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-25 [patent_title] => 'HBV/HCV virus-like particle' [patent_app_type] => B1 [patent_app_number] => 09/721480 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 21796 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740323.pdf [firstpage_image] =>[orig_patent_app_number] => 09721480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1317615 [patent_doc_number] => 06605426 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-12 [patent_title] => 'Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products' [patent_app_type] => B1 [patent_app_number] => 09/716504 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 36 [patent_no_of_words] => 48639 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605426.pdf [firstpage_image] =>[orig_patent_app_number] => 09716504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1336399 [patent_doc_number] => 06589522 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Vaccines against infections caused by YF virus; YF infectious cDNA, method for producing a recombinant YF virus from the YF infectious cDNA and plasmids to assemble the YF infectious cDNA' [patent_app_type] => B1 [patent_app_number] => 09/705949 [patent_app_country] => US [patent_app_date] => 2000-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10992 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/589/06589522.pdf [firstpage_image] =>[orig_patent_app_number] => 09705949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1279912 [patent_doc_number] => 06646115 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Identification of transcription factor within a cAMP-responsive transcriptional enhancer binding protein (CREB), and uses therefore' [patent_app_type] => B1 [patent_app_number] => 09/686316 [patent_app_country] => US [patent_app_date] => 2000-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15671 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/646/06646115.pdf [firstpage_image] =>[orig_patent_app_number] => 09686316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1453158 [patent_doc_number] => 06461810 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Triplex in-situ hybridization' [patent_app_type] => B1 [patent_app_number] => 09/531000 [patent_app_country] => US [patent_app_date] => 2000-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 9086 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/461/06461810.pdf [firstpage_image] =>[orig_patent_app_number] => 09531000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414457 [patent_doc_number] => 06518033 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Method of detecting the presence of CD155 for diagnosis of cancer and to determine treatment' [patent_app_type] => B1 [patent_app_number] => 09/655744 [patent_app_country] => US [patent_app_date] => 2000-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 7194 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518033.pdf [firstpage_image] =>[orig_patent_app_number] => 09655744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311317 [patent_doc_number] => 06610471 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Methods and compositions to investigate infection by hepatitis B virus and agents to prevent and treat the infection' [patent_app_type] => B1 [patent_app_number] => 09/600731 [patent_app_country] => US [patent_app_date] => 2000-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 50 [patent_no_of_words] => 16312 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610471.pdf [firstpage_image] =>[orig_patent_app_number] => 09600731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1336524 [patent_doc_number] => 06589531 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Recombinant yellow fever virus and method of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/653754 [patent_app_country] => US [patent_app_date] => 2000-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 12479 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/589/06589531.pdf [firstpage_image] =>[orig_patent_app_number] => 09653754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1245091 [patent_doc_number] => 06676936 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Chimeric and/or growth-restricted flaviviruses' [patent_app_type] => B1 [patent_app_number] => 09/643217 [patent_app_country] => US [patent_app_date] => 2000-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 32 [patent_no_of_words] => 28764 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/676/06676936.pdf [firstpage_image] =>[orig_patent_app_number] => 09643217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357234 [patent_doc_number] => 06573058 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Antibody to herpes virus entry receptor protein' [patent_app_type] => B1 [patent_app_number] => 09/631780 [patent_app_country] => US [patent_app_date] => 2000-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 11775 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573058.pdf [firstpage_image] =>[orig_patent_app_number] => 09631780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1331725 [patent_doc_number] => 06596529 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/602288 [patent_app_country] => US [patent_app_date] => 2000-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 18063 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596529.pdf [firstpage_image] =>[orig_patent_app_number] => 09602288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1296955 [patent_doc_number] => 06627437 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-30 [patent_title] => 'GBV sequence' [patent_app_type] => B1 [patent_app_number] => 09/579302 [patent_app_country] => US [patent_app_date] => 2000-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11892 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627437.pdf [firstpage_image] =>[orig_patent_app_number] => 09579302 [rel_patent_id] =>[rel_patent_doc_number] =>)